ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 D09.3

Billable / Specific

Carcinoma in situ of thyroid and other endocrine glands

D09
Block
0
Synonyms
295
LCDs
16
Payer Policies
1
Linked CPTs

About ICD-10-CM D09.3

ICD-10-CM code D09.3 represents Carcinoma in situ of thyroid and other endocrine glands. This is a billable/specific code in the Neoplasms chapter (block D09). The 2026 edition of ICD-10-CM D09.3 became effective on October 1, 2025.

Type 1 Excludes

Pure excludes, these codes can never be coded together with D09.3. The conditions are mutually exclusive (e.g., congenital vs acquired forms).

  • carcinoma in situ of endocrine pancreas (D01.7)
  • carcinoma in situ of ovary (D07.39)
  • carcinoma in situ of testis (D07.69)

Medicare LCD Coverage for D09.3

Local Coverage Determinations (LCDs) from CMS MACs that list D09.3 as a covered diagnosis.

295 LCDs

Showing top 10 of 295 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81215 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81300 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81351 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81167 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81405 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 0103U →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81201 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81297 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81298 →
CMS LCD: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
Article ID: 58734, Effective: 2025-10-01 00:00:00, 268 covered, 0 non-covered
CPT 81299 →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing D09.3.

16 policies

1 Aetna

Positron Emission Tomography (PET) - Medical Clinical Policy Bulletins | Aetna
Policy ID: CPB-0071

1 Cigna

Head and Neck Ultrasound - (0549)
Policy ID: MM_0549

5 Medicare

Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
Policy ID: ART-52480
Billing and Coding: Cardiac Blood Pool Imaging (Multiple Gated Acquisition Scanning- MUGA, Ventriculography) When Performed in Conjunction with Cardiotoxic Chemotherapy
Policy ID: ART-54768
Billing and Coding: Computerized Axial Tomography (CT), Thorax
Policy ID: ART-56580
Billing and Coding: Implantable Infusion Pump
Policy ID: ART-56695
Billing and Coding: White Cell Colony Stimulating Factors
Policy ID: ART-56748

CPT Codes Commonly Billed with D09.3

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

1 linkages
  • 76536 CMS LCD: Billing and Coding: Ultrasound, Soft Tissues of Head and Neck CMS LCD

Convert D09.3 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
D09.3 2348 10000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 D09.3, Billing FAQ

Is ICD-10 code D09.3 billable? +

Yes, D09.3 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What codes are Type 1 Excludes for D09.3? +

Type 1 Excludes (never code together with D09.3): carcinoma in situ of endocrine pancreas (D01.7); carcinoma in situ of ovary (D07.39); carcinoma in situ of testis (D07.69)

What CPT codes are commonly billed with D09.3? +

Procedures frequently paired with D09.3 include: 76536.

What ICD-9 codes does D09.3 map to? +

Per CMS GEMs, D09.3 maps to ICD-9 codes: 2348. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on June 1, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included